Muhammad Zohaib Khan. FREQUENCY OF END OF TREATMENT RESPONSE IN GENOTYPE 3 CIRRHOTIC PATIENTS TAKING SOFOSBUVIR, RIBAVIRIN AND DACLATASVIR. J Popl Ther Clin Pharmacol 2024, 31 (9), 4104-4128. https://doi.org/10.53555/vgped651.